nootkatone has been researched along with Ureteral Obstruction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doye, P; Gairola, S; Kulhari, U; Mugale, MN; Murty, US; Ram, C; Sahu, BD; Syed, AM | 1 |
1 other study(ies) available for nootkatone and Ureteral Obstruction
| Article | Year |
|---|---|
Nootkatone confers antifibrotic effect by regulating the TGF-β/Smad signaling pathway in mouse model of unilateral ureteral obstruction.
Topics: Animals; Disease Models, Animal; Fibrosis; Humans; Kidney; Kidney Failure, Chronic; Male; Mice; Polycyclic Sesquiterpenes; Signal Transduction; Smad Proteins; Transforming Growth Factor beta; Ureteral Obstruction | 2021 |